These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10090596)

  • 61. Chemotherapy for Chagas' disease: a perspective of current therapy and considerations for future research.
    Marr JJ; Docampo R
    Rev Infect Dis; 1986; 8(6):884-903. PubMed ID: 3025994
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impact of benznidazole on infection course in mice experimentally infected with Trypanosoma cruzi I, II, and IV.
    Gruendling AP; Massago M; Teston AP; Monteiro WM; Kaneshima EN; Araújo SM; Gomes ML; Barbosa Md; Toledo MJ
    Am J Trop Med Hyg; 2015 Jun; 92(6):1178-89. PubMed ID: 25940197
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection.
    Villar JC; Marin-Neto JA; Ebrahim S; Yusuf S
    Cochrane Database Syst Rev; 2002; (1):CD003463. PubMed ID: 11869663
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antiparasitical chemotherapy in Chagas' disease cardiomyopathy: current evidence.
    Matta Guedes PM; Gutierrez FR; Nascimento MS; Do-Valle-Matta MA; Silva JS
    Trop Med Int Health; 2012 Sep; 17(9):1057-65. PubMed ID: 22686518
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antitrypanosomal therapy for chronic Chagas' disease.
    Bern C
    N Engl J Med; 2011 Jun; 364(26):2527-34. PubMed ID: 21714649
    [No Abstract]   [Full Text] [Related]  

  • 66. Chemotherapy of Trypanosoma cruzi infections.
    Brener Z
    Adv Pharmacol Chemother; 1975; 13():1-81. PubMed ID: 812348
    [No Abstract]   [Full Text] [Related]  

  • 67. Novel [1,2,3]triazolo[1,5-a]pyridine derivatives are trypanocidal by sterol biosynthesis pathway alteration.
    Lapier M; Ballesteros-Garrido R; Guzman-Rivera D; González-Herrera F; Aguilera-Venegas B; Moncada-Basualto M; Ballesteros R; Abarca B; Pesce B; Kemmerling U; Olea-Azar C; Maya JD
    Future Med Chem; 2019 May; 11(10):1137-1155. PubMed ID: 31280672
    [No Abstract]   [Full Text] [Related]  

  • 68. Antitrypanosomal therapy for chronic Chagas' disease.
    Garcia-Bournissen F; Altcheh J
    N Engl J Med; 2011 Sep; 365(13):1258; author reply 1259. PubMed ID: 21991908
    [No Abstract]   [Full Text] [Related]  

  • 69. Antitrypanosomal therapy for chronic Chagas' disease.
    Bestetti RB; Cardinalli-Neto A
    N Engl J Med; 2011 Sep; 365(13):1258-9; author reply 1259. PubMed ID: 21991909
    [No Abstract]   [Full Text] [Related]  

  • 70. A comparative study of posaconazole and benznidazole in the prevention of heart damage and promotion of trypanocidal immune response in a murine model of Chagas disease.
    Olivieri BP; Molina JT; de Castro SL; Pereira MC; Calvet CM; Urbina JA; Araújo-Jorge TC
    Int J Antimicrob Agents; 2010 Jul; 36(1):79-83. PubMed ID: 20452188
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
    Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F
    Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Response to chemotherapy with benznidazole of clones isolated from the 21SF strain of Trypanosoma cruzi (biodeme Type II, Trypanosoma cruzi II).
    Campos RF; Guerreiro ML; Sobral Kde S; Lima Rde C; Andrade SG
    Rev Soc Bras Med Trop; 2005; 38(2):142-6. PubMed ID: 15821788
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Polymerase chain reaction (PCR) as a laboratory tool for the evaluation of the parasitological cure in Chagas disease after specific treatment.
    Britto C; Cardoso A; Silveira C; Macedo V; Fernandes O
    Medicina (B Aires); 1999; 59 Suppl 2():176-8. PubMed ID: 10668261
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A proteomic analysis of the mechanism of action of naphthoimidazoles in Trypanosoma cruzi epimastigotes in vitro.
    Menna-Barreto RF; Beghini DG; Ferreira AT; Pinto AV; De Castro SL; Perales J
    J Proteomics; 2010 Nov; 73(12):2306-15. PubMed ID: 20621210
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Trypanosoma cruzi-Specific T-Cell Responses to Monitor Treatment Efficacy in Chronic Chagas Disease.
    Albareda MC; Natale MA; Cesar GL; Castro Eiro MD; Alvarez MG; Laucella SA
    Methods Mol Biol; 2019; 1955():339-348. PubMed ID: 30868539
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antiproliferative effects of delta 24(25) sterol methyl transferase inhibitors on Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies.
    Urbina JA; Vivas J; Lazardi K; Molina J; Payares G; Piras MM; Piras R
    Chemotherapy; 1996; 42(4):294-307. PubMed ID: 8804798
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial.
    Morillo CA; Waskin H; Sosa-Estani S; Del Carmen Bangher M; Cuneo C; Milesi R; Mallagray M; Apt W; Beloscar J; Gascon J; Molina I; Echeverria LE; Colombo H; Perez-Molina JA; Wyss F; Meeks B; Bonilla LR; Gao P; Wei B; McCarthy M; Yusuf S;
    J Am Coll Cardiol; 2017 Feb; 69(8):939-947. PubMed ID: 28231946
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The use of posaconazole against Chagas disease.
    Molina I; Salvador F; Sánchez-Montalvá A
    Curr Opin Infect Dis; 2015 Oct; 28(5):397-407. PubMed ID: 26203852
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Treatment of Chagas' disease].
    Apt W
    Rev Med Chil; 1985 Feb; 113(2):162-6. PubMed ID: 3936147
    [No Abstract]   [Full Text] [Related]  

  • 80. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease.
    Brener Z; Gazzinelli RT
    Int Arch Allergy Immunol; 1997 Oct; 114(2):103-10. PubMed ID: 9338602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.